ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
6 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
4 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR Medicine |
Re:
LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review
|
|
JamesTas
|
16 |
6.5K |
15 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
16
|
6.5K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
4 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
4 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
0 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
3 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
1 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
1
|
|
ASX - By Stock
|
ABB |
Re:
Ann: Aussie launches digital first challenger brand
|
|
JamesTas
|
32 |
14K |
4 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
32
|
14K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
5 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
706
|
249K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day 2024 - scurvy dogs o' the ASX
|
|
JamesTas
|
105 |
26K |
3 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
105
|
26K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day 2024 - scurvy dogs o' the ASX
|
|
JamesTas
|
105 |
26K |
3 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
105
|
26K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day 2024 - scurvy dogs o' the ASX
|
|
JamesTas
|
105 |
26K |
1 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
105
|
26K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
11 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
706
|
249K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
8 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
706
|
249K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
4 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
JamesTas
|
52 |
20K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
52
|
20K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
5 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
706
|
249K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
4 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
12 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
12
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
JamesTas
|
52 |
18K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
52
|
18K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Application for quotation of securities - PAR
|
|
JamesTas
|
14 |
4.6K |
3 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
14
|
4.6K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
JamesTas
|
52 |
18K |
3 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
52
|
18K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.3K |
1.9M |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
4.3K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
lowest ever
|
|
JamesTas
|
5 |
2.9K |
12 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
5
|
2.9K
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JamesTas
|
21K |
7.5M |
3 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
21K
|
7.5M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
JamesTas
|
104 |
32K |
9 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
32K
|
9
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
51K |
0 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
51K
|
0
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
51K |
6 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
51K
|
6
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
51K |
0 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
51K
|
0
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
51K |
2 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
117
|
51K
|
2
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
51K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
117
|
51K
|
1
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
51K |
4 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
117
|
51K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
8 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
6 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
JamesTas
|
236 |
94K |
7 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
94K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
706
|
249K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
706
|
249K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
JamesTas
|
670 |
258K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
670
|
258K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
JamesTas
|
46 |
17K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
17K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
JamesTas
|
46 |
17K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
17K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
706
|
249K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
706
|
249K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
20 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
706
|
249K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
706 |
249K |
24 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
706
|
249K
|
24
|
|
ASX - By Stock
|
PAR |
Re:
Resolution of lumbar bone marrow oedema
|
|
JamesTas
|
76 |
36K |
16 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
76
|
36K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.8M |
11 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
11
|
|